Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Diabetes Mellitus, Insulin-Dependent, 12
×
pembrolizumab
×
Clear all
Filters
3
NCT03058289
2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2
Completed
111 enrolled
21 charts
NCT03302234
2023-09-26
KEYNOTE-598
Merck Sharp & Dohme LLC
Phase 3
Completed
568 enrolled
20 charts